Australia markets closed

Castle Biosciences, Inc. (CSTL)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
30.64+2.16 (+7.58%)
At close: 04:00PM EDT
31.16 +0.52 (+1.70%)
After hours: 04:15PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
98,124
94,085
62,649
51,865
22,786
Cost of revenue
18,738
15,822
9,685
7,310
5,297
Gross profit
79,386
78,263
52,964
44,555
17,489
Operating expenses
Research development
34,499
29,646
13,256
7,385
4,854
Selling general and administrative
99,030
86,738
48,132
29,842
16,470
Total operating expenses
139,697
118,342
59,506
37,227
21,325
Operating income or loss
-60,311
-40,079
-6,542
7,328
-3,836
Interest expense
4
1
2,634
4,571
2,274
Total other income/expenses net
-
-
-1,397
2,280
-272.417
Income before tax
-60,221
-40,012
-10,200
5,349
-6,358
Income tax expense
-8,586
-8,720
84
72
8.606
Income from continuing operations
-51,635
-31,292
-10,284
5,277
-6,367
Net income
-51,635
-31,292
-10,284
5,277
-6,367
Net income available to common shareholders
-51,635
-31,292
-10,284
2,991
-6,095
Basic EPS
-
-1.24
-0.54
0.35
-0.62
Diluted EPS
-
-1.24
-0.54
-0.21
-0.62
Basic average shares
-
25,137
18,929
8,584
9,784
Diluted average shares
-
25,137
18,929
8,658
9,784
EBITDA
-
-36,604
-7,094
10,278
-3,762